Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
NTLA on Nasdaq
Shares outstanding
116,932,531
Price per share
$13.90
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
104,076,200
Total reported value
$935,658,582
% of total 13F portfolios
0%
Share change
-398,850
Value change
-$52,666,820
Number of holders
286
Price from insider filings
$13.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 12% +11% $127,723,843 +$20,570,433 14,207,324 +19% ARK Investment Management LLC 31 Dec 2025
VANGUARD GROUP INC 11% +12% $116,959,909 +$25,352,232 13,010,001 +28% The Vanguard Group 31 Dec 2025
BlackRock, Inc. 8.2% $70,244,546 8,453,014 BlackRock, Inc. 31 Mar 2025
STATE STREET CORP 5.5% +28% $73,367,295 +$21,815,012 6,418,836 +42% STATE STREET CORPORATION 31 Dec 2025
GOLDMAN SACHS GROUP INC 2.7% -48% $36,086,548 -$26,758,590 3,157,178 -43% THE GOLDMAN SACHS GROUP, INC. 31 Dec 2025
Contrarius Investment Management Ltd 0.6% -82% $8,166,506 -$59,155,462 714,480 -88% Contrarius Investment Management Ltd 31 Dec 2025

As of 31 Dec 2025, 286 institutional investors reported holding 104,076,200 shares of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA). This represents 89% of the company’s total 116,932,531 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARK Investment Management LLC 12% 14,207,324 +19% 0.85% $127,723,840
VANGUARD GROUP INC 11% 13,010,001 +18% 0% $116,959,909
BlackRock, Inc. 8.8% 10,276,849 +11% 0% $92,388,870
STATE STREET CORP 5.5% 6,418,836 +29% 0% $57,705,336
D. E. Shaw & Co., Inc. 4.6% 5,331,064 +139% 0.04% $47,926,266
REGENERON PHARMACEUTICALS, INC. 3.2% 3,702,995 0% 98% $33,289,925
TWO SIGMA INVESTMENTS, LP 2.3% 2,698,738 +10% 0.04% $24,261,655
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,696,187 +4.1% 0% $24,242,683
TWO SIGMA ADVISERS, LP 2% 2,346,317 +8.5% 0.04% $21,093,390
MORGAN STANLEY 2% 2,327,852 -61% 0% $20,927,396
Sumitomo Mitsui Trust Group, Inc. 1.9% 2,192,461 -6.9% 0.01% $19,710,224
Amova Asset Management Americas, Inc. 1.9% 2,192,461 -6.9% 0.23% $19,688,300
DIMENSIONAL FUND ADVISORS LP 1.7% 1,931,849 +9.9% 0% $17,367,448
FMR LLC 1.5% 1,759,898 -5% 0% $15,821,480
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1.5% 1,737,450 +7.9% 0.05% $15,619,676
RENAISSANCE TECHNOLOGIES LLC 1.4% 1,672,700 +157% 0.02% $15,037,573
GOLDMAN SACHS GROUP INC 1.2% 1,455,619 -66% 0% $13,086,015
BANK OF AMERICA CORP /DE/ 1.1% 1,242,378 +105% 0% $11,168,977
ARMISTICE CAPITAL, LLC 0.99% 1,156,000 +72% 0.25% $10,392,440
JUPITER ASSET MANAGEMENT LTD 0.89% 1,037,918 -24% 0.07% $9,330,883
CITADEL ADVISORS LLC 0.81% 950,250 +9077% 0.01% $8,542,748
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.81% 945,756 +8.3% 0% $8,502,346
STIFEL FINANCIAL CORP 0.8% 931,391 +20% 0.01% $8,373,255
NORTHERN TRUST CORP 0.75% 872,579 -3.7% 0% $7,844,485
UBS Group AG 0.74% 859,552 -22% 0% $7,727,373

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 104,076,200 $935,658,582 -$52,666,820 $8.99 286
2025 Q3 104,167,644 $1,798,715,383 +$103,220,845 $17.27 280
2025 Q2 99,520,897 $933,579,792 -$6,825,658 $9.38 277
2025 Q1 101,252,381 $719,981,345 +$1,659,582 $7.11 289
2024 Q4 99,191,549 $1,156,525,724 -$49,302,844 $11.66 288
2024 Q3 93,188,112 $1,914,885,599 +$52,687,081 $20.55 277
2024 Q2 90,118,237 $2,016,932,908 -$33,057,144 $22.38 286
2024 Q1 90,994,794 $2,502,941,003 +$158,724,377 $27.51 279
2023 Q4 85,253,157 $2,599,308,572 +$153,798,142 $30.49 289
2023 Q3 80,150,230 $2,534,451,262 +$57,616,066 $31.62 281
2023 Q2 78,283,933 $3,190,579,654 -$9,432,957 $40.78 288
2023 Q1 78,716,838 $2,928,484,579 +$27,166,066 $37.27 288
2022 Q4 78,108,132 $2,724,660,295 +$325,216,887 $34.89 294
2022 Q3 68,149,786 $3,811,906,455 -$6,962,154 $55.96 308
2022 Q2 67,593,487 $3,442,253,307 +$98,077,804 $51.76 282
2022 Q1 65,174,223 $4,718,129,955 -$27,349,229 $72.67 341
2021 Q4 64,197,108 $7,594,973,150 +$200,734,926 $118.24 361
2021 Q3 62,179,774 $8,341,966,333 +$38,202,306 $134.15 354
2021 Q2 61,943,081 $10,039,072,441 +$39,075,135 $161.91 329
2021 Q1 62,997,292 $5,055,620,165 +$268,264,167 $80.25 255
2020 Q4 61,851,171 $3,364,841,363 +$187,799,640 $54.40 239
2020 Q3 56,492,124 $1,125,276,243 +$49,648,218 $19.88 161
2020 Q2 53,928,267 $1,127,243,500 +$160,801,520 $21.02 160
2020 Q1 46,446,764 $568,083,328 +$9,021,271 $12.23 133
2019 Q4 45,615,533 $669,178,528 +$24,351,485 $14.67 137
2019 Q3 44,102,636 $588,745,766 +$69,153,421 $13.35 131
2019 Q2 38,816,811 $635,365,544 +$86,588,206 $16.37 142
2019 Q1 33,462,480 $569,908,589 +$44,514,644 $17.08 142
2018 Q4 31,523,455 $430,244,776 +$12,114,608 $13.65 136
2018 Q3 29,098,874 $832,839,044 +$7,443,896 $28.62 149
2018 Q2 28,851,341 $789,266,553 +$71,304,782 $27.36 151
2018 Q1 26,414,691 $557,070,367 +$49,316,700 $21.09 127
2017 Q4 24,300,186 $467,047,800 +$127,200,241 $19.22 110
2017 Q3 17,671,668 $439,163,056 +$20,668,372 $24.85 84
2017 Q2 16,801,771 $268,836,976 +$2,831,017 $16.00 81
2017 Q1 16,738,696 $235,847,748 -$10,683,400 $14.09 73
2016 Q4 18,384,582 $241,018,660 -$6,133,604 $13.11 67
2016 Q3 14,253,796 $242,822,100 +$573,360 $17.02 64
2016 Q2 14,055,535 $300,085,720 +$298,405,720 $21.35 61
2016 Q1 215 $4,000 $18.60 1